Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
Your Choice for President
Now that the presidential debates are over and the election less than two weeks away, we would like to know who you believe will be the stronger supporter of biotechnology. This includes the whole of life science research, industrial biotechnology, and commercial biotechnology. The idea of support not only covers government funding for basic biotech R&D. It also extends to the creation of a healthy business environment where biofirms can raise money to carry out their various projects and feel secure that their intellectual property and patents are adequately protected. The broader issue involves the choice of someone who will keep the U.S. in the forefront of biotech research in an increasingly globalized and competitive world.